Taken together, these results suggest that osteogenesis inhibition is closely coupled with angiogenesis impairment, which contributes to the inhibition of tibial bone formation and leads to the occurrence of TD through alterations of the Ca/P ratio and OPG/RANKL system. The gene discussed is TNFRSF11B; the disease is thanatophoric dysplasia.